IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

Cellular Plasticity and Disease News

Scientific
New keys to understanding inflammation associated with ageing
Institutional
World Cancer Day 2024: Highlights of IRB Barcelona’s cancer research
Scientific
Chemotherapy becomes more efficient when senescent cells are eliminated by immunotherapy
Scientific
Iron accumulation: a new insight into fibrotic diseases
Scientific
Vitamin B12: a key player in cellular reprogramming and tissue regeneration
Immune cell infiltrate (in deep red) around senescent cancer cells (large nuclei marked in blue).
Media mentions
Células senescentes como vacuna contra el cáncer - BioTech
Immune cell infiltrate (in deep red) around senescent cancer cells (large nuclei marked in blue).
Scientific
Senescent cells as vaccines against cancer
Media mentions
El envejecimiento no es irreversible - La Vanguardia
Media mentions
Descifrar el envejecimiento no nos hará inmortales, pero frenaría las enfermedades degenerativas: "Sería un cambio radical" - rTVE
Scientific
Researchers at IRB Barcelona rejuvenate mouse organs through cellular reprogramming
Institutional
The Spanish Association Against Cancer backs IRB Barcelona research with more than €3M
Institutional
Three projects with the participation of IRB Barcelona, awarded a “Seed Grant” from the BIST Ignite programme
Innovation
IRB Barcelona launches a scientific collaboration with Galapagos to identify and validate senolytic drug targets in inflammation and fibrosis
Institutional
Manuel Serrano wins the 48th Leopold Griffuel Award for fundamental cancer research
Cell plasticity: different and reversible identities (Cian J. Lynch, IRB Barcelona)
Scientific
Researchers discover a new method to regulate cell plasticity
Manuel Serrano
Institutional
IRB Barcelona researchers awarded an ERC grant to develop new drugs against fibrosis
Manuel Serrano, head of the Cell Plasticity and Disease Laboratory at IRB Barcelona
Media mentions
“It’s important to age healthily. I think that is something we would all like,” says Manuel Serrano in an interview
Manuel Serrano, researcher at IRB Barcelona
Media mentions
“Living forever is not around the corner. We study aging in order to tackle associated diseases”
Manuel Serrano, researcher at IRB Barcelona
Media mentions
Can treatments for cell senescence bring about the end of diseases related to aging?
Manuel Serrano, ICREA researcher at IRB Barcelona, during his talk at the Barcelona Biomed Conference.
Media mentions
Immunotherapy paves the way beyond cancer
Manuel Serrano, ICREA researcher at IRB Barcelona, during his talk at the Barcelona Biomed Conference.
Institutional
International scientists point to immunotherapy as a new approach for treating diseases related to ageing
Manuel Serrano, IRB Barcelona.
Media mentions
Manuel Serrano: “It makes no sense to talk about something as intangible as imortality”
Manuel Serrano, IRB Barcelona.
Media mentions
The Geroscience event has been held in Europe for the first time
Marta Kovatcheva, postdoctoral researcher at IRB Barcelona
Media mentions
Marta Kovatcheva's research receives 160,000 euros of funding thanks to the Women's Race of the AECC La Rioja
100tífiques. Source: FCRI
Outreach
Gathering of “100tífiques”: fostering education to change stereotypes that drive girls away from science
Source: COPE
Media mentions
IV Women's Race for Research
Manuel Serrano, group leader of the Cellular Plasticity and Disease laboratory
Media mentions
Rejuvenate and program cells to cure cancer and diabetes
Manuel Serrano leads the Cellular Plasticity and Disease group at IRB Barcelona
Media mentions
Zombie cells: responsible for damage in the organism
The AECC ceremony was held in Madrid yesterday, 25th September, the World Cancer Research Day
Institutional
The Spanish Association Against Cancer awards funding to five projects at IRB Barcelona
Manuel Serrano, head of the Cellular Plasticity and Disease laboratory at IRB Barcelona
Institutional
“Cell damage is happening in our bodies all the time”